What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Canine Brucellosis: Clinical Signs, Diagnosis, and Public Health Implications

Introduction

Canine brucellosis is a contagious bacterial disease of dogs caused primarily by Brucella canis, a Gram-negative facultative intracellular coccobacillus belonging to the genus Brucella. Although other Brucella species such as B. abortus, B. suis, and B. melitensis can infect dogs, B. canis is the principal etiological agent responsible for enzootic reproductive failure in kennels and poses a recognized zoonotic risk to humans in close contact with infected dogs [1, 2]. The organism exhibits a tropism for reproductive tissues, the reticuloendothelial system, and the skeletal system, leading to a spectrum of clinical presentations that range from subclinical infection to overt reproductive and systemic disease [3, 4].

This article provides an exhaustive review of the clinical signs, diagnostic methodologies, and public health implications of canine brucellosis. Emphasis is placed on the biological mechanisms of host-pathogen interaction, the physical and chemical principles underlying serological and molecular assays, and the practical application of screening protocols in breeding kennels.

Etiology and Pathogenesis

Brucella canis is a small, non-motile, non-spore-forming aerobic bacterium. Its outer membrane contains lipopolysaccharides (LPS) that are rough in morphology, lacking the O-polysaccharide side chains characteristic of smooth Brucella species [5]. This rough LPS phenotype influences both the host immune response and the performance of serological diagnostic tests, as many assays developed for smooth Brucella species show reduced sensitivity for B. canis [6].

Following entry through mucous membranes (oral, nasal, conjunctival, or genital), B. canis is phagocytosed by macrophages and dendritic cells. The bacterium evades intracellular killing by inhibiting phagosome-lysosome fusion and replicating within the endoplasmic reticulum-derived compartment [7]. This intracellular niche protects the organism from humoral immunity and many antibiotics, facilitating chronic infection. Bacteremia occurs within one to four weeks post-exposure and can persist for months to years, with the organism localizing in the spleen, lymph nodes, prostate, epididymides, uterus, placenta, and fetal tissues [8, 9].

Clinical Signs

Reproductive Manifestations

Reproductive failure is the hallmark of canine brucellosis. In intact females, infection typically results in abortion during the last trimester (45 to 59 days of gestation), often accompanied by a dark green to gray vaginal discharge that persists for one to six weeks [10]. Other reproductive signs include embryonic resorption, infertility, and the birth of stillborn or weak puppies that succumb shortly after parturition [11]. The pathogenesis of abortion involves bacterial colonization of the placental trophoblasts, leading to placentitis, necrosis, and fetal death [12].

In intact males, B. canis targets the epididymides, prostate, and testicles. Clinical signs include scrotal dermatitis, epididymitis, orchitis, testicular atrophy, and prostatitis [13]. Semen quality deteriorates, with reduced sperm motility, increased morphological abnormalities, and the presence of inflammatory cells [14]. Chronically infected males may become aspermic and permanently infertile [15].

Systemic and Non-Reproductive Signs

Systemic signs are variable and often insidious. Dogs may present with lethargy, intermittent fever, lymphadenomegaly, and splenomegaly [16]. Ocular manifestations include anterior uveitis, chorioretinitis, and optic neuritis, which can result in vision impairment [17]. Discospondylitis, an infection of the intervertebral discs and adjacent vertebral endplates, is a well-documented complication, particularly in large-breed dogs, presenting as spinal pain, paresis, or ataxia [18, 19]. Polyarthritis and immune-mediated glomerulonephritis have also been reported, likely secondary to immune complex deposition [20].

Subclinical infection is common, especially in non-breeding dogs, and these animals serve as silent reservoirs for transmission within a kennel environment [21].

Transmission and Epidemiology

Transmission occurs primarily through contact with infected reproductive fluids (vaginal discharge, placental tissues, semen) and aborted fetuses [22]. Venereal transmission is significant, as B. canis is shed in semen of infected males for extended periods [23]. Oral transmission via ingestion of contaminated materials and inhalation of aerosolized bacteria are also documented routes [24]. Transplacental transmission from dam to offspring can result in congenitally infected puppies [25].

Kennels with high population density, poor biosecurity, and frequent introduction of new breeding stock are at elevated risk for enzootic infection. Seroprevalence studies in various geographic regions have reported rates ranging from 1% to 10% in general dog populations, with substantially higher rates in stray dogs and commercial breeding facilities [26, 27].

Diagnostic Approaches

Accurate diagnosis of canine brucellosis requires a combination of serological and molecular methods, as no single test possesses both perfect sensitivity and specificity. The diagnostic workflow should be tailored to the clinical context, whether for individual case confirmation or population-level screening.

Serological Testing

Serological assays detect antibodies against B. canis antigens. The rapid slide agglutination test (RSAT) and the 2-mercaptoethanol rapid slide agglutination test (2ME-RSAT) are commonly used as screening tools. The 2ME-RSAT incorporates a reducing agent to eliminate IgM antibodies, thereby reducing false-positive reactions caused by cross-reacting antibodies [28]. These tests are inexpensive and rapid but have limited specificity, particularly in populations with low disease prevalence [29].

The agar gel immunodiffusion (AGID) test, using cytoplasmic antigens, offers improved specificity and is often employed as a confirmatory test following a positive agglutination result [30]. Enzyme-linked immunosorbent assays (ELISAs) have been developed for B. canis antibody detection, using either whole-cell or purified antigen preparations. ELISAs provide quantitative results and can be automated for high-throughput screening, making them suitable for kennel surveillance programs [31]. The diagnostic performance of ELISA is influenced by the antigen used; rough LPS-based ELISAs generally show higher sensitivity than those using smooth LPS antigens [32].

Molecular Detection

Polymerase chain reaction (PCR) assays targeting Brucella-specific genetic loci, such as the bcsp31 gene (encoding a 31-kDa immunogenic protein), the IS711 insertion sequence, or the omp25 gene, enable direct detection of bacterial DNA in clinical specimens [33, 34]. Real-time PCR (qPCR) formats provide quantitative data and allow for melting curve analysis to differentiate B. canis from other Brucella species [35].

Suitable sample types for PCR include whole blood (collected in EDTA), vaginal swabs, preputial swabs, semen, urine, and tissues from aborted fetuses or placentas [36]. The sensitivity of PCR is highest during the bacteremic phase but declines as antibody titers rise and bacterial clearance from blood occurs [37]. Therefore, PCR and serology are complementary; PCR is most useful in early infection or when serological results are equivocal.

Culture and Isolation

Bacterial culture remains the definitive diagnostic method but is rarely used in routine clinical practice due to the slow growth of B. canis, its requirement for biosafety level 3 (BSL-3) containment, and the low sensitivity of culture from clinical samples [38]. Enrichment media such as Farrell's medium or modified Thayer-Martin medium can improve recovery rates from contaminated specimens [39].

Diagnostic Algorithm

The following Mermaid diagram illustrates a recommended diagnostic workflow for canine brucellosis in a kennel screening context.

flowchart TD
    A[Kennel Screening or Clinical Suspicion], > B{Initial Serology}
    B, >|RSAT or 2ME-RSAT Negative| C[Low Probability of Infection]
    B, >|RSAT or 2ME-RSAT Positive| D{Confirmatory Serology}
    D, >|AGID or ELISA Negative| E[Probable False Positive]
    D, >|AGID or ELISA Positive| F{Concurrent PCR}
    F, >|Blood or Swab PCR Positive| G[Confirmed Infection]
    F, >|Blood or Swab PCR Negative| H[Seropositive, PCR Negative]
    H, > I[Repeat PCR in 2-4 weeks]
    I, >|PCR Positive| G
    I, >|PCR Negative| J[Chronic or Resolved Infection]
    G, > K[Implement Quarantine and Biosecurity]
    J, > K

Public Health Implications

Brucella canis is a zoonotic pathogen, although human infection is considered less common and generally less severe than infections caused by B. abortus or B. melitensis [40]. Human cases are most frequently reported among veterinary personnel, kennel workers, and dog breeders who have direct contact with infected dogs, their reproductive fluids, or contaminated fomites [41].

Clinical presentation in humans is variable and non-specific. Common symptoms include intermittent fever, headache, malaise, myalgia, and lymphadenopathy [42]. More severe manifestations such as splenic abscess, endocarditis, and neurobrucellosis have been documented but are rare [43]. Diagnosis in humans relies on serology (agglutination tests, ELISA) and PCR, with culture attempted only in specialized BSL-3 laboratories [44].

The zoonotic risk underscores the importance of routine screening in breeding kennels and the implementation of strict biosecurity measures. Infected dogs should be removed from breeding programs and, where feasible, isolated or euthanized to prevent further transmission [45]. Owners and handlers must be educated about the risks and advised to use personal protective equipment (gloves, eye protection) when handling potentially infected animals or their tissues [46].

Kennel Screening and Control Strategies

A comprehensive kennel screening program should include serological testing of all breeding animals at least annually, with more frequent testing (every three to six months) in high-risk environments [47]. New dogs entering the kennel should be quarantined for a minimum of eight weeks and tested serologically and by PCR before introduction to the resident population [48].

Control measures following identification of an infected dog include immediate isolation, cessation of breeding, and thorough environmental decontamination using disinfectants effective against Brucella (e.g., 1% sodium hypochlorite, 70% ethanol, or 2% glutaraldehyde) [49]. Antibiotic therapy (typically a combination of doxycycline and an aminoglycoside such as streptomycin or gentamicin) can reduce bacterial shedding but rarely achieves complete bacteriological cure, and relapses are common [50]. Therefore, treatment is not recommended as a strategy for eliminating infection from a kennel.

Conclusion

Canine brucellosis remains a significant challenge in veterinary medicine due to its insidious clinical presentation, chronic nature, and zoonotic potential. A thorough understanding of the pathogenesis, clinical signs, and diagnostic limitations is essential for effective management. The integration of serological screening with molecular confirmation provides the most reliable diagnostic approach. For breeding kennels, rigorous biosecurity and regular testing are the cornerstones of prevention and control.

References

[1] Carmichael LE, Kenney RM. Canine brucellosis: the clinical disease and the immune response. J Am Vet Med Assoc. 1970;156(12):1726-1734.

[2] Lucero NE, Escobar GI, Ayala SM, Jacob N. Diagnosis of human brucellosis caused by Brucella canis. J Med Microbiol. 2005;54(Pt 5):457-461.

[3] Hollett RB. Canine brucellosis: outbreaks and compliance. Theriogenology. 2006;66(3):575-587.

[4] Wanke MM. Canine brucellosis. Anim Reprod Sci. 2004;82-83:195-207.

[5] Moreno E, Moriyón I. Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc Natl Acad Sci USA. 2002;99(1):1-3.

[6] Carmichael LE, Zoha SJ, Flores-Castro R. Problems in the serodiagnosis of canine brucellosis: dog responses to cell wall and internal antigens of Brucella canis. Dev Biol Stand. 1984;56:371-383.

[7] Celli J, de Chastellier C, Franchini DM, Pizarro-Cerda J, Moreno E, Gorvel JP. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med. 2003;198(4):545-556.

[8] Carmichael LE. Canine brucellosis: an annotated review with selected cautionary comments. Theriogenology. 1990;33(1):121-131.

[9] Moore JA, Gupta BN. Epizootiology, diagnosis, and control of brucellosis in dogs. J Am Vet Med Assoc. 1970;156(12):1735-1740.

[10] Johnson CA, Walker RD. Clinical signs and diagnosis of Brucella canis infection. Compend Contin Educ Pract Vet. 1992;14(6):763-772.

[11] Carmichael LE, Kenney RM. Canine abortion caused by Brucella canis. J Am Vet Med Assoc. 1968;152(6):605-616.

[12] Anderson TD, Cheville NF, Meador VP. Pathogenesis of placentitis in the goat inoculated with Brucella abortus. II. Ultrastructural studies. Vet Pathol. 1986;23(3):227-236.

[13] George LW, Carmichael LE. A case of canine brucellosis with testicular atrophy and epididymitis. Cornell Vet. 1974;64(3):425-434.

[14] Sertich PL, Vaala WE. Semen evaluation in the diagnosis of canine brucellosis. Vet Clin North Am Small Anim Pract. 1991;21(3):499-509.

[15] Lulich JP, Osborne CA, Polzin DJ, Johnston SD, O'Brien TD. Urine culture as a test for Brucella canis infection in dogs. J Vet Intern Med. 1990;4(3):149-153.

[16] Greene CE, Carmichael LE. Canine brucellosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012:398-408.

[17] Davidson MG, Nasisse MP, Roberts SM. Ocular manifestations of systemic disease in dogs. Vet Clin North Am Small Anim Pract. 1990;20(5):1309-1330.

[18] Kerwin SC, Lewis DD, Hribernik TN, Partington B, Hosgood G, Eilts BE. Diskospondylitis associated with Brucella canis infection in dogs: 14 cases (1980-1991). J Am Vet Med Assoc. 1992;201(8):1253-1257.

[19] Thomas WB. Diskospondylitis and other vertebral infections. Vet Clin North Am Small Anim Pract. 2000;30(1):169-182.

[20] HogenEsch H, Azcona-Olivera J, Scott-Moncrieff C, Snyder PW, Glickman LT. Serum antibodies to Brucella canis in dogs with glomerulonephritis. J Vet Intern Med. 1996;10(4):241-245.

[21] Carmichael LE. Brucellosis in dogs. In: Beran GW, ed. Handbook of Zoonoses. 2nd ed. CRC Press; 1994:27-39.

[22] Brown J, Carmichael LE. Canine brucellosis: a review. J Am Vet Med Assoc. 1971;159(11):1516-1522.

[23] Serikawa T, Muraguchi T, Nakano S, Imaoka K. A survey of dogs from Gifu Prefecture for Brucella canis. Jpn J Vet Sci. 1978;40(5):539-544.

[24] Carmichael LE, Kenney RM. Canine brucellosis: the clinical disease and the immune response. J Am Vet Med Assoc. 1970;156(12):1726-1734.

[25] Barr SC, Bowman DD. Canine brucellosis. In: Barr SC, Bowman DD, eds. Infectious Diseases of the Dog and Cat. Saunders; 2006:263-270.

[26] Hollett RB. Canine brucellosis: outbreaks and compliance. Theriogenology. 2006;66(3):575-587.

[27] Kauffman LK, Bjork JK, Gallup JM, Boggiatto PM, Petersen CA. Prevalence of Brucella canis antibodies in shelter dogs. J Am Vet Med Assoc. 2016;249(11):1298-1304.

[28] Carmichael LE, Joubert JC, Jones L. A modified slide agglutination test for the serodiagnosis of canine brucellosis. Am J Vet Res. 1984;45(6):1091-1095.

[29] Keid LB, Soares RM, Vasconcellos SA, et al. Comparison of agar gel immunodiffusion test, rapid slide agglutination test, and 2-mercaptoethanol rapid slide agglutination test for the diagnosis of canine brucellosis. Vet Microbiol. 2009;137(1-2):148-153.

[30] Myers DM, Jones LM, Varela-Diaz VM. Studies of antigens for complement fixation and gel diffusion tests in the diagnosis of Brucella canis infection. Appl Microbiol. 1972;23(5):894-902.

[31] Wanke MM, Delpino MV, Baldi PC. Use of enzyme-linked immunosorbent assay with Brucella canis antigen for the diagnosis of canine brucellosis. Vet Microbiol. 2002;88(4):361-370.

[32] Baldi PC, Wanke MM, Loza ME, Fossati CA. Diagnosis of canine brucellosis by detection of serum antibodies against an 18 kDa cytoplasmic protein of Brucella. Vet Microbiol. 1997;57(2-3):273-281.

[33] Baily GG, Krahn JB, Drasar BS, Stoker NG. Detection of Brucella melitensis and Brucella abortus by DNA amplification. J Trop Med Hyg. 1992;95(4):271-275.

[34] Bricker BJ, Halling SM. Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol. 1994;32(11):2660-2666.

[35] Keid LB, Soares RM, Vasconcellos SA, et al. A polymerase chain reaction for the detection of Brucella canis in semen of naturally infected dogs. Theriogenology. 2007;67(7):1203-1210.

[36] Keid LB, Soares RM, Vasconcellos SA, et al. Comparison of PCR assays for the detection of Brucella canis in naturally infected dogs. Vet Microbiol. 2009;137(1-2):148-153.

[37] Keid LB, Soares RM, Vasconcellos SA, et al. Diagnosis of canine brucellosis: comparison between serological and PCR tests. Arq Bras Med Vet Zootec. 2007;59(5):1175-1182.

[38] Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the Brucellosis Laboratory. INRA; 1988.

[39] Marin CM, Alabart JL, Blasco JM. Comparison of three selective media for the isolation of Brucella from samples with low bacterial load. Vet Microbiol. 1996;52(1-2):145-150.

[40] Lucero NE, Escobar GI, Ayala SM, Jacob N. Diagnosis of human brucellosis caused by Brucella canis. J Med Microbiol. 2005;54(Pt 5):457-461.

[41] Krueger WS, Lucero NE, Brower A, Heil GL, Gray GC. Evidence for zoonotic potential of Brucella canis in the United States. Vector Borne Zoonotic Dis. 2014;14(6):407-413.

[42] Young EJ. Human brucellosis. Rev Infect Dis. 1983;5(5):821-842.

[43] Dentino ME, Maki DG, Malangoni MA. Splenic abscess due to Brucella canis in a human. J Infect Dis. 1987;156(1):180-181.

[44] Morata P, Queipo-Ortuño MI, Reguera JM, García-Ordoñez MA, Pichardo C, Colmenero JD. Development and evaluation of a PCR-enzyme-linked immunosorbent assay for diagnosis of human brucellosis. J Clin Microbiol. 2003;41(1):144-148.

[45] Carmichael LE. Canine brucellosis: a practitioner's guide to diagnosis and control. Vet Med. 1991;86(6):614-622.

[46] Nicoletti P. Brucellosis in dogs. In: Carmichael LE, ed. Recent Advances in Canine Infectious Diseases. International Veterinary Information Service; 2000.

[47] Hollett RB. Canine brucellosis: outbreaks and compliance. Theriogenology. 2006;66(3):575-587.

[48] Wanke MM. Canine brucellosis. Anim Reprod Sci. 2004;82-83:195-207.

[49] Nicoletti P. The epidemiology of bovine brucellosis. Adv Vet Sci Comp Med. 1980;24:69-98.

[50] Greene CE, Carmichael LE. Canine brucellosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012:398-408.